icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2015
50th Annual Meeting of the European
Association for the Study of the Liver
Vienna, Austria  April 22-26
Back grey_arrow_rt.gif
 
 
 
Daclatasvir Plus Sofosbuvir for Treatment of HCV Genotypes 1-4 in HIV-HCV Coinfection: The ALLY-2 Study
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
Wyles DL,1 Ruane P,2 Sulkowski MS,3 Dieterich D,4 Luetkemeyer AF,5 Morgan TR,6 Sherman KE,7 Liu Z,8 Noviello S,8 Ackerman P8
1University of California, San Diego, CA, USA; 2Ruane Medical and Liver Health Institute, Los Angeles, CA, USA; 3Johns Hopkins University School of Medicine, Baltimore, MD, USA; 4Icahn School of Medicine at Mount Sinai, New York, NY, USA; 5University of California and San Francisco General Hospital, San Francisco, CA, USA; 6VA Long Beach Healthcare System, Long Beach, CA, USA; 7University of Cincinnati College of Medicine, Cincinnati, OH, USA; 8Bristol-Myers Squibb, Princeton, NJ, USA.

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif